Google
ILMN — ILLUMINA INC (Healthcare >> Diagnostics & Research)
ILMN FAQ
What is ILMN's P/E ratio?
ILLUMINA INC (ILMN) currently trades at a P/E ratio of 28.83.
What is ILMN's ROE?
ILLUMINA INC reports a Return on Equity (ROE) of 31.88%.
What is ILMN's dividend yield?
ILLUMINA INC offers a dividend yield of 0.00%.
What is ILMN's Deepscope Quality Score?
Deepscope rates ILMN's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ILMN?
Deepscope's AI Timing Score for ILMN is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ILMN belong to?
ILLUMINA INC is classified under the Healthcare >> Diagnostics & Research sector on the NASDAQ exchange.
|
USD 170.93
Price
8.38
(5.16%)
Day Change
|
|
|---|
ILMN, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is ok , ...
| Quality Factors |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.08 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
1090
|
| Magic Formula Rank by ROE |
1090
|
| Magic Formula Rank by ROIC |
1281
|
| Price | 170.93 |
| PBV / Sector |
9.19 / -23.97
|
| Earning Per Share | 5.93 |
| PE / Sector |
28.83 / 36.92
|
| PEG or PE/Growth / Sector |
-0.36 / 1.37
|
| Average 1M Daily Value |
275.07 M
GREAT
|
| Average 1W Daily Value |
390.09 M
GREAT
|
| Timing Factors |
|
85% |
| Financial Health |
|
54% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-04 09:24:13 |
| Symbol | ILMN |
| Name | ILLUMINA INC |
| Sector | Healthcare >> Diagnostics & Research |
| Market | NASDAQ |
| Listed Shares | 151.30 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 24,593.82 / 31,486.64 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5200 Illumina Way, San Diego, CA, United States, 92122
Phone: 858 202 4500
Website: https://www.illumina.com
Employees: 8,600
Description: Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Diagnostics & Research
Click a bubble to view stock details · Bubble size represents market capitalization share
